NASDAQ:NRXP
NRx Pharmaceuticals, Inc. Stock Company Profile
$3.54
+0.400 (+12.74%)
At Close: Apr 26, 2024
Information
1201 Orange Street, Suite 600
Wilmington DE 19801
484 254 6134
www.nrxpharma.com
Industry: Biotechnology
Sector: Healthcare
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
